Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03139240 · ClinicalTrials.gov registry record · Phase 4
Opioid Analgesia for MAB
A Phase 4 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 172
- Enrollment target
NCT03139240 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 172 participants.
The verdict
NCT03139240, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 172 participants
- Enrollment target
Study Summary
Our primary objective will be to determine if a strong opioid, oxycodone, given at a dose recommended for severe pain in addition to ibuprofen decreases maximum pain scores compared to ibuprofen and placebo in women undergoing medical abortion (MAB). Results of this study will help future providers understand whether prescribing opioids are an important adjunct for pain control in women undergoing MAB.
Interventions
- OTHER Placebo
- DRUG Oxycodone 10mg oral
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2018-05-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03139240
The ClinicalTrials.gov registry entry for NCT03139240 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03139240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03139240 about?
NCT03139240 is a clinical study titled "Opioid Analgesia for MAB". Our primary objective will be to determine if a strong opioid, oxycodone, given at a dose recommended for severe pain in addition to ibuprofen decreases maximum pain scores compared to ibuprofen and placebo in women undergoing medical abortion (MAB). Results of this study will help future providers ...
What is the current status of trial NCT03139240?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 172 participants. The study started on 2017-05-01. Estimated completion is 2018-05-31.
What interventions are being tested in trial NCT03139240?
The interventions under investigation include: Placebo (OTHER), Oxycodone 10mg oral (DRUG).
Who is sponsoring clinical trial NCT03139240?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.